-
Vaccine development - 25/05/2021
Having long been considered less lucrative for the big pharmaceutical companies, vaccine development is taking off in an unforeseen way in the wake of the COVID-19 pandemic. Financial support is flooding in and all kinds of vaccine development strategies are being deployed. Among the winners in the competition for effective coronavirus vaccines are vaccines based on RNA technology.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/vaccines-beacon-hope-fight-against-pandemics
-
Dossier - 02/12/2013
The 15-year history of RNA interference is not short on dramatic effects. It begins with the unexpected discovery and publication of the process of post-transcriptional gene silencing in 1998 for which Andrew Fire and Craig Mello were awarded the Nobel Prize in Physiology or Medicine just eight years after their discovery. In 2001 Thomas Tuschl succeeded in switching off genes in human cells with small synthetic pieces of RNA siRNA.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/rna-interference-confidence-is-returning
-
Dossier - 10/11/2014
While cell therapy has become standard treatment for a number of blood cancers, most cell and gene therapy approaches for the treatment of hereditary and metabolic diseases, neurodegenerative disorders and cancer are still in the experimental phases or early clinical trials. However, recent successes give rise to the hope that cell and gene therapies will in future make important contributions to previously incurable diseases.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/cell-and-gene-therapies-from-bench-to-bedside
-
-
-
-
-
-
-
-
Press release - 19/09/2024
Personalized medicine with individually tailored therapies is becoming more a reality in cancer. This requires a look into the genetic material of tumors, a molecular diagnostic tumor profile. A research group from the German Network for Personalized Medicine (DNPM) has recorded the quality standards according to which genome analyses are carried out in Germany. The data is a prerequisite for integrating gene sequencing into routine care.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/quality-standards-looking-tumor-genome
-
-
-
Sustainable medical technology - 10/10/2024
Good healthcare relies heavily on medical products made from plastic. However, the widespread use of synthetic materials, particularly disposable items, creates vast amounts of waste, depletes resources and leads to a substantial carbon footprint. To create more environmentally friendly plastic products in the future, substantial changes to production processes are essential.
https://www.gesundheitsindustrie-bw.de/en/article/news/rethinking-plastics-medical-technology
-
-
-
-
-
-
NMI project WOUNDSENS - 23/10/2024
Monitoring the condition of chronic, non-healing wounds requires wound dressings to be changed at short, regular intervals. In the EU-funded WOUNDSENS project, researchers at the NMI in Reutlingen are using electrospinning to produce novel types of wound dressings. These consist of biosensory fibres that send information about the condition of the wound to the outside, thereby improving inflammation detection.
https://www.gesundheitsindustrie-bw.de/en/article/news/wound-monitoring-using-sensory-nanofibres
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Press release - 14/11/2024
Making existing cancer therapy more efficient while significantly reducing the side effects on healthy tissue - this is the aim of a project at Aalen University. It is being funded with one million euros from the Carl Zeiss Foundation. The biophysicist and his team are developing innovative nanoparticles made of gold. The particles use radiotherapy and chemotherapy simultaneously and kill the cancer cells in a targeted manner.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-method-for-fighting-tumors
-
-
-
-
-
-
-
Website address: https://www.biooekonomie-bw.de/en/search